Home › Opioid Overdose › NCT05729932
Cannabis and Opioid Use Disorder
RecruitingPhase 1Healthy volunteers welcome
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety
Who can join
Ages 18 to 55 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Current opioid use disorder Exclusion Criteria: * Current medical conditions that require medical management
About the study
This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.
What is being tested
- Inhaled vaporized cannabis (drug)
- Intransal opioid (drug)
Sponsor: Shanna Babalonis, PhD · Participants: 15 · Started: Sep 10, 2024
Contact the study team
- Paul Nuzzo, MA · Phone: 859-323-0002
Official record on ClinicalTrials.gov — NCT05729932
Locations in the U.S.
| Kentucky | Center on Drug and Alcohol Research, Lexington |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.